1 Min Read
April 6 (Reuters) - Pacira Pharmaceuticals Inc:
* PACIRA ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR EXPAREL® AS A NERVE BLOCK TO PRODUCE REGIONAL ANALGESIA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.